{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:34:11Z","timestamp":1789907651828,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"16","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.vaccine.2015.01.080","type":"journal-article","created":{"date-parts":[[2015,2,9]],"date-time":"2015-02-09T22:31:33Z","timestamp":1423521093000},"page":"1987-1992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013\u2013June 2014"],"prefix":"10.1016","volume":"33","author":[{"given":"Penina","family":"Haber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro L.","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brock","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.01.080_bib0170","unstructured":"Food and Drug Administration. June 17, 2003 approval letter-Influenza virus vaccine lives intranasal. http:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm123753.htm [accessed February 2014]."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0175","unstructured":"MedImmune, INC. FluMist\u00ae Package Insert (circular). http:\/\/www.medimmune.com\/docs\/default-source\/pdfs\/flumist_pi.pdf [accessed September 2013]."},{"issue":"RR07","key":"10.1016\/j.vaccine.2015.01.080_bib0180","first-page":"1","article-title":"Centers for Disease Control and Prevention (CDC). Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), United States","volume":"62","author":"Grohskopf","year":"2013","journal-title":"MMWR"},{"issue":"32","key":"10.1016\/j.vaccine.2015.01.080_bib0185","first-page":"691","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP) \u2013 United States, 2014\u201315 influenza season","volume":"63","author":"Centers for Disease Control and Prevention (CDC)","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0190","unstructured":"Food and Drug Administration. FluMist\u00ae Quadrivalent (Influenza Vaccine Live, Intranasal). http:\/\/www.fda.gov\/downloads\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/UCM294307.pdf [accessed 02.07.12]."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0195","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1016\/j.vaccine.2011.09.109","article-title":"A randomized double-blinded noninferiority study of quadrivalent live attenuated influenza vaccine in adults","volume":"29","author":"Block","year":"2011","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2015.01.080_bib0200","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1586\/erv.12.108","article-title":"Quadravalent Ann Arbor Strain live-attenuated influenza vaccine","volume":"11","author":"Toback","year":"2012","journal-title":"Expert Rev Vaccin"},{"issue":"7","key":"10.1016\/j.vaccine.2015.01.080_bib0205","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/INF.0b013e31825687b0","article-title":"Immunogenicity and safety of a quadrivalent live attenuated influenza vaccine in children","volume":"31","author":"Block","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.080_bib0210","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00006454-200404000-00002","article-title":"Understanding vaccine safety information from the Vaccine Adverse Event Reporting System","volume":"23","author":"Varricchio","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2015.01.080_bib0215","first-page":"1","article-title":"Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS) United States, 1991\u20132001","volume":"52","author":"Zhou","year":"2003","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0220","unstructured":"Medical Dictionary for Regulatory Activities. http:\/\/www.meddramsso.com [accessed 13.02.13]."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0225","unstructured":"Code of Federal Regulations. 21 CFR \u00a7600.80. http:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfcfr\/CFRSearch.cfm?fr=600.80 [revised 01.04.10]."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0230","series-title":"Proceeding of the conference on knowledge discovery and data","first-page":"67","article-title":"Empirical Bayes screening for multi-item associations","author":"DuMouchel","year":"2001"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00002018-200225060-00001","article-title":"Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's Spontaneous Reports database","volume":"25","author":"Szarfman","year":"2002","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0240","doi-asserted-by":"crossref","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","article-title":"Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United State, October 1, 2009\u2013January 31, 2010","volume":"28","author":"Vellozzi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0245","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain-Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0250","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"Ruggeberg","year":"2007","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2015.01.080_bib0255","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1001\/jama.294.21.2720","article-title":"Adverse events reported following live cold-adapted intranasal influenza vaccine","volume":"294","author":"Izurieta","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0260","series-title":"Vaccine Adverse Event Reporting System (VAERS)","article-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in children aged 2\u201318 years","author":"Haber","year":"2014"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0265","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1016\/j.vaccine.2014.09.018","article-title":"Post-licensure surveillance of trivalent live attenuated influenza vaccine in adults, United States, Vaccine Adverse Event Reporting System (VAERS), July 2005\u2013June 2013","volume":"32","author":"Haber","year":"2014","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.080_bib0270","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States, 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0275","series-title":"Adverse effects of vaccines: evidence and causality","author":"IOM (Institute of Medicine)","year":"2011"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.080_bib0280","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000324710","article-title":"Population incidence of Guillain-Barr\u00e9 syndrome: a systematic review and meta-analysis","volume":"36","author":"Sejvar","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"8","key":"10.1016\/j.vaccine.2015.01.080_bib0285","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/cid\/ciu005","article-title":"Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence","volume":"58","author":"Vellozzi","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2015.01.080_bib0290","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2105\/AJPH.2013.301651","article-title":"Cumulative risk of Guillain-Barr\u00e9 syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic","volume":"104","author":"Vellozzi","year":"2014","journal-title":"Am J Public Health"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.080_bib0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/cid\/cit222","article-title":"Lack of association of Guillain-Barr\u00e9 syndrome with vaccinations","volume":"57","author":"Baxter","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00006454-200201000-00010","article-title":"Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma","volume":"21","author":"Redding","year":"2002","journal-title":"Pediatr Infect Dis. J"},{"key":"10.1016\/j.vaccine.2015.01.080_bib0305","unstructured":"Brendan F. Update on Effectiveness of Live-Attenuated Versus Inactivated Influenza Vaccines in Children and Adolescents Aged 2-18 Years \u2013 US Flu VE Network Advisory Committee on Immunization Practice (ACIP) Meeting Presentation October 29, 2014. Available at http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2014-10\/flu-03-flannery."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0310","unstructured":"Ambrose C. Effectiveness study: Preliminary results from 2013\u201314. MedImmune. Advisory Committee on Immunization Practice (ACIP) meeting presentation October 29, 2014. Available at http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2014-10\/flu-03-flannery."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0315","unstructured":"Cost A. Influenza vaccine effectiveness: air force children, 2013\u20132014 influenza season, Advisory Committee on Immunization Practice (ACIP) meeting presentation October 29, 2014. Available at http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2014-10\/flu-03-flannery."},{"key":"10.1016\/j.vaccine.2015.01.080_bib0320","series-title":"Preventing medication errors: quality chasm series. Committee on identifying and preventing medication errors","author":"IOM (Institute of Medicine)","year":"2007"},{"issue":"35","key":"10.1016\/j.vaccine.2015.01.080_bib0325","first-page":"773","article-title":"Notes from the field: reports of expired live attenuated influenza vaccine being administered \u2013 United States, 2007\u20132014","volume":"63","author":"Haber","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2015.01.080_bib0330","doi-asserted-by":"crossref","first-page":"146.e1","DOI":"10.1016\/j.ajog.2010.08.050","article-title":"Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990\u20132009","volume":"204","author":"Moro","year":"2011","journal-title":"Am J Obstet Gynecol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15001474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T09:55:12Z","timestamp":1537869312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15001474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":33,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0264410X15001474"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.080","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-licensure surveillance of quadrivalent live attenuated influenza vaccine United States, Vaccine Adverse Event Reporting System (VAERS), July 2013\u2013June 2014","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.01.080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}